Arima M and Fukuda T |
Prostaglandin Dâ‚‚ and T(H)2 inflammation in the pathogenesis of bronchial asthma. |
2011 |
Korean J. Intern. Med. |
pmid:21437156
|
MartÃnez-Gras I et al. |
The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia. |
2011 |
Schizophr. Res. |
pmid:21334179
|
Chbicheb S et al. |
EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells. |
2011 |
Biochem. Pharmacol. |
pmid:21338579
|
Qiu Z et al. |
Cough reflex sensitivity and airway inflammation in patients with chronic cough due to non-acid gastro-oesophageal reflux. |
2011 |
Respirology |
pmid:21342332
|
Wang JJ and Mak OT |
Induction of apoptosis by 15d-PGJ2 via ROS formation: an alternative pathway without PPARγ activation in non-small cell lung carcinoma A549 cells. |
2011 |
Prostaglandins Other Lipid Mediat. |
pmid:21396480
|
Murata T et al. |
Prostagladin D2 is a mast cell-derived antiangiogenic factor in lung carcinoma. |
2011 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:22106279
|
Aung G et al. |
Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines. |
2011 |
Immunology |
pmid:21214543
|
Hovsepian E et al. |
Modulation of inflammatory response and parasitism by 15-Deoxy-Δ(12,14) prostaglandin J(2) in Trypanosoma cruzi-infected cardiomyocytes. |
2011 |
Int. J. Parasitol. |
pmid:21215746
|
Lotz C et al. |
Activation of peroxisome-proliferator-activated receptors α and γ mediates remote ischemic preconditioning against myocardial infarction in vivo. |
2011 |
Exp. Biol. Med. (Maywood) |
pmid:21163821
|
Charles RL et al. |
Redox regulation of soluble epoxide hydrolase by 15-deoxy-delta-prostaglandin J2 controls coronary hypoxic vasodilation. |
2011 |
Circ. Res. |
pmid:21164107
|
Cichocka-Jarosz E et al. |
Serum tryptase level is a better predictor of systemic side effects than prostaglandin D2 metabolites during venom immunotherapy in children. |
2011 |
J Investig Allergol Clin Immunol |
pmid:21721371
|
Galvão Nascimento N et al. |
Contribution of mast cells to the oedema induced by Bothrops moojeni snake venom and a pharmacological assessment of the inflammatory mediators involved. |
2010 Feb-Mar |
Toxicon |
pmid:19703484
|
Mutalithas K et al. |
CRTH2 expression on T cells in asthma. |
2010 |
Clin. Exp. Immunol. |
pmid:20491797
|
Koharudin LM et al. |
Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1. |
2010 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:20231490
|
Norman P |
DP(2) receptor antagonists in development. |
2010 |
Expert Opin Investig Drugs |
pmid:20615077
|
Pedersen PJ et al. |
Prostaglandin phospholipid conjugates with unusual biophysical and cytotoxic properties. |
2010 |
Bioorg. Med. Chem. Lett. |
pmid:20591667
|
Bai YJ et al. |
A LC-MS-based method for quantification of biomarkers from serum of allergic rats. |
2010 |
Molecules |
pmid:20657485
|
Reddy RC and Standiford TJ |
Nrf2 and PPAR{gamma}: PPARtnering against oxidant-induced lung injury. |
2010 |
Am. J. Respir. Crit. Care Med. |
pmid:20634499
|
Ahmad AS et al. |
Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice. |
2010 |
Age (Dordr) |
pmid:20640551
|
Shah S et al. |
Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia. |
2010 |
Int. J. Clin. Pract. |
pmid:20518948
|
Genovese A et al. |
Human cardiac mast cells in anaphylaxis. |
2010 |
Chem Immunol Allergy |
pmid:20519884
|
Diers AR et al. |
Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy. |
2010 |
Biochem. J. |
pmid:20536428
|
Vong L et al. |
A pro-resolution mediator, prostaglandin D(2), is specifically up-regulated in individuals in long-term remission from ulcerative colitis. |
2010 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:20547854
|
Akin C et al. |
Mast cell activation syndrome: Proposed diagnostic criteria. |
2010 |
J. Allergy Clin. Immunol. |
pmid:21035176
|
Zhang HX et al. |
Alteration of biochemical and pathological properties of TDP-43 protein by a lipid mediator, 15-deoxy-Delta(12,14)-prostaglandin J(2). |
2010 |
Exp. Neurol. |
pmid:20083106
|
Katura T et al. |
15-Deoxy-delta 12,14-prostaglandin J2 biphasically regulates the proliferation of mouse hippocampal neural progenitor cells by modulating the redox state. |
2010 |
Mol. Pharmacol. |
pmid:20086036
|
Buga GM et al. |
L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation. |
2010 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19965777
|
Roy SJ et al. |
Characterization of C-terminal tail determinants involved in CRTH2 receptor trafficking: identification of a recycling motif. |
2010 |
Eur. J. Pharmacol. |
pmid:20035740
|
Lin TY and London CA |
Characterization and modulation of canine mast cell derived eicosanoids. |
2010 |
Vet. Immunol. Immunopathol. |
pmid:20036014
|
Byrns MC et al. |
Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer. |
2010 |
J. Steroid Biochem. Mol. Biol. |
pmid:20036328
|
Templeton DJ et al. |
Purification of reversibly oxidized proteins (PROP) reveals a redox switch controlling p38 MAP kinase activity. |
2010 |
PLoS ONE |
pmid:21085594
|
Moraes LA et al. |
Non-genomic effects of PPARgamma ligands: inhibition of GPVI-stimulated platelet activation. |
2010 |
J. Thromb. Haemost. |
pmid:20040043
|
Subra C et al. |
Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. |
2010 |
J. Lipid Res. |
pmid:20424270
|
Hatanaka M et al. |
15d-prostaglandin J2 enhancement of nerve growth factor-induced neurite outgrowth is blocked by the chemoattractant receptor- homologous molecule expressed on T-helper type 2 cells (CRTH2) antagonist CAY10471 in PC12 cells. |
2010 |
J. Pharmacol. Sci. |
pmid:20424389
|
Maggiora M et al. |
Involvement of PPARα and PPARγ in apoptosis and proliferation of human hepatocarcinoma HepG2 cells. |
2010 |
Cell Biochem. Funct. |
pmid:20862655
|
Uehara Y |
[Prostaglandin D2 and related substances]. |
2010 |
Nippon Rinsho |
pmid:20960740
|
Hanks BC et al. |
Evaluation of anti-inflammatory and chondroprotective effects of peroxisome proliferator-activated receptor gamma agonists in cartilage and synovial explants from dogs. |
2010 |
Am. J. Vet. Res. |
pmid:20919899
|
Kim NJ et al. |
Concise and enantioselective total synthesis of 15-deoxy-Δ-(12,14)-prostaglandin J(2). |
2010 |
J. Org. Chem. |
pmid:20929274
|
Bancos S et al. |
Induction of heme oxygenase-1 in normal and malignant B lymphocytes by 15-deoxy-Delta(12,14)-prostaglandin J(2) requires Nrf2. |
2010 |
Cell. Immunol. |
pmid:20064636
|
Lee JJ et al. |
The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase. |
2010 |
Arch. Pharm. Res. |
pmid:20361303
|
Pérez-Novo CA et al. |
CRTH2 mediates the activation of human Th2 cells in response to PGD(2) released from IgE/anti-IgE treated nasal polyp tissue. |
2010 |
Allergy |
pmid:19839971
|
Mo C et al. |
PPARgamma regulates LIF-induced growth and self-renewal of mouse ES cells through Tyk2-Stat3 pathway. |
2010 |
Cell. Signal. |
pmid:19922793
|
Kanda N et al. |
Prostaglandin D2 induces the production of human beta-defensin-3 in human keratinocytes. |
2010 |
Biochem. Pharmacol. |
pmid:19925780
|
Biburger M et al. |
Pivotal Advance: Heme oxygenase 1 expression by human CD4+ T cells is not sufficient for their development of immunoregulatory capacity. |
2010 |
J. Leukoc. Biol. |
pmid:19797297
|
Toaldo C et al. |
PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cells. |
2010 |
J. Cell. Mol. Med. |
pmid:19912441
|
Diers AR et al. |
Mitochondrial targeting of the electrophilic lipid 15-deoxy-Delta12,14-prostaglandin J2 increases apoptotic efficacy via redox cell signalling mechanisms. |
2010 |
Biochem. J. |
pmid:19916962
|
Morgenweck J et al. |
Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema. |
2010 |
Neuropharmacology |
pmid:19891980
|
Mishra N et al. |
Inhibition of mitochondrial division through covalent modification of Drp1 protein by 15 deoxy-Delta(12,14)-prostaglandin J2. |
2010 |
Biochem. Biophys. Res. Commun. |
pmid:20307494
|
Guo N et al. |
Mast cell-derived prostaglandin D2 controls hyaluronan synthesis in human orbital fibroblasts via DP1 activation: implications for thyroid eye disease. |
2010 |
J. Biol. Chem. |
pmid:20308056
|
Poncin S et al. |
N-acetylcysteine and 15 deoxy-{delta}12,14-prostaglandin J2 exert a protective effect against autoimmune thyroid destruction in vivo but not against interleukin-1{alpha}/interferon {gamma}-induced inhibitory effects in thyrocytes in vitro. |
2010 |
Am. J. Pathol. |
pmid:20489149
|